| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Pittman Scott M. | 12% | $12,903,115 | 5,610,050 | Pittman Scott M. | 23 Jan 2026 | |||
| Jacobs Paul Anthony | 6.6% | $6,526,175 | 3,183,500 | Jacobs Paul Anthony | 23 Jan 2026 |
As of 31 Dec 2025, 1 institutional investors reported holding 4,700 shares of Nuo Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AURX). This represents 0.01% of the company’s total 48,234,848 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 4,700 | $9,259 | $1.97 | 1 | |
| 2025 Q3 | 4,700 | $9,588 | $2.04 | 1 | |
| 2025 Q2 | 4,700 | $7,050 | $1.50 | 1 | |
| 2025 Q1 | 4,700 | $5,640 | $1.20 | 1 | |
| 2024 Q4 | 4,700 | $6,580 | $1.40 | 1 | |
| 2024 Q3 | 4,700 | $2,737 | $0.58 | 1 | |
| 2024 Q2 | 4,700 | $1,774 | $0.38 | 1 | |
| 2024 Q1 | 4,700 | $3,407 | $0.72 | 1 | |
| 2023 Q4 | 4,700 | $2,585 | $0.55 | 1 | |
| 2023 Q3 | 4,700 | $2,820 | $0.60 | 1 | |
| 2023 Q2 | 4,700 | $5,875 | $1.25 | 1 | |
| 2023 Q1 | 4,700 | $8,460 | $1.80 | 1 | |
| 2022 Q4 | 4,700 | $7,000 | $1.49 | 1 | |
| 2022 Q3 | 4,700 | $13,000 | +$13,000 | $2.77 | 1 |